John Porter

Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom.

Part of Novartis AG, Novartis Vaccines & Diagnostics Ltd. is a healthcare company based in Liverpool, UK that provides solutions to address the evolving needs of patients worldwide. The British company offers information and resources for healthcare professionals about Novartis medicines through the Novartis HCP Portal. Novartis Ireland Limited is the Irish affiliate of Swiss-based Novartis AG, one of the largest pharmaceutical companies in the world. Novartis is one of Liverpool's leading employers in the healthcare industry and has a strong history of investing in the city over the last sixty years.